MAPT and early-onset autosomal dominant Alzheimer disease: There is also some biochemical and clinical datasuggesting that p53 activation might play a role in human diseases of aging.Recent reports have shown that p53 activation can trigger the pathways thatpromote tau protein aggregation, which in turn is thought to reflect specificstages in Alzheimer's disease [10].